Name changed to Evonile Pharma Limited with effect from October 01, 2026; fresh Certificate of Incorporation issued

Company name changed from Novartis India Limited to Evonile Pharma Limited.

Thu 1 Oct 2026

Certificate of Incorporation

fresh Certificate of Incorporation issued on October 01, 2026

Effective date of name change

with effect from October 01, 2026

Shareholder approval

Special Resolution at the 78th Annual General Meeting held on September 24, 2026

Constitutional documents amended

MoA Name Clause and the Articles of Association amended to reflect the new name

Stakeholder impact

change does not affect the rights and liabilities of stakeholders

What happened

• The Ministry of Corporate Affairs, Government of India, issued a fresh Certificate of Incorporation on October 01, 2026.
• Consequent to this, the name of the company has been changed from Novartis India Limited to Evonile Pharma Limited, with effect from October 01, 2026.
• The company refers to its earlier communication dated August 17, 2026.

How the change was approved

• Shareholders of the company approved the change by way of a Special Resolution passed at the 78th Annual General Meeting held on September 24, 2026.
• The Ministry of Corporate Affairs, Government of India, granted its consequent approval, and the fresh Certificate of Incorporation was issued.

Which company documents have changed

• Clause I (Name Clause) of the Memorandum of Association has been amended to reflect the new name of the company as Evonile Pharma Limited.
• The Articles of Association stand amended, wherever applicable, to substitute the existing name Novartis India Limited with Evonile Pharma Limited.
• The disclosure, along with the amended constitutional documents, is also being made available on the company's website.

What the certificate records

• The company is limited by shares, and its Corporate Identification Number remains the same.
• The company was originally incorporated with the name CIBA PHARMA PRIVATE LIMITED.
• The change of name does not affect the rights and liabilities of stakeholders.
• It is obligatory on the part of the company to display the old name for a period of two years along with its new name at all places where a company is required to display its name, in terms of Section 12 of the Companies Act.

What this means for a retail shareholder

• This is a change of the company's name, not a change in its shareholding, its shares or its legal identity.
• The shares continue in the same company; the certificate states that the change of name does not affect the rights and liabilities of stakeholders.
• The letter to the exchange is marked with the existing scrip code 500672, which is how the shares are identified on BSE.
• The name appearing on the exchange, on the company's website and in its records will change to Evonile Pharma Limited; the company will continue to display the old name alongside the new one for two years.

What to watch

• Any further intimations on the company's website and stock-exchange updates will now appear under the new name, Evonile Pharma Limited.
• Investors who track the company by its earlier name should note the change so that future updates are not missed.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.